Cited by 312

The DOI matches its Crossref record.

Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice

Buhman, Kimberly K., Accad, Michel, Novak, Sabine, Choi, Rebekah S., Wong, Jinny S., Hamilton, Robert L., Turley, Stephen, Farese, Robert V.·2000·Nature Medicine

Abstract

The importance of cholesterol ester synthesis by acyl CoA:cholesterol acyltransferase (ACAT) enzymes in intestinal and hepatic cholesterol metabolism has been unclear. We now demonstrate that ACAT2 is the major ACAT in mouse small intestine and liver, and suggest that ACAT2 deficiency has profound effects on cholesterol metabolism in mice fed a cholesterol-rich diet, including complete resistance to diet-induced hypercholesterolemia and cholesterol gallstone formation. The underlying mechanism involves the lack of cholesterol ester synthesis in the intestine and a resultant reduced capacity to absorb cholesterol. Our results indicate that ACAT2 has an important role in the response to dietary cholesterol, and suggest that ACAT2 inhibition may be a useful strategy for treating hypercholesterolemia or cholesterol gallstones.

Overview

Integrity signals

Registry

Crossref · 10.1038/82153

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Treatment with ezetimibe protects mice from diet-induced hypercholesterolemia and atherosclerosis.

    “Treatment with EZ protects mice from diet-induced hypercholesterolemia and atherosclerosis (1, 3, 12, 13).”
  • Free cholesterol deposited into the inner leaflet of the apical plasma membrane by NPC1L1 must subsequently move to the endoplasmic reticulum to be esterified by ACAT2.

    “Free cholesterol deposited into the inner leaflet of the apical PM by NPC1L1 must subsequently move to the ER to be esterified by ACAT2 (3–5).”

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 38

  1. Bloch, K. Cholesterol: Evolution of structure and function. in Biochemistry of Lipids, Lipoproteins and Membranes (eds. Vance, D.E. & Vance, J.) 363–381 (Elsevier,–Amsterdam, 1991).
  2. Chang, T.Y., Chang, C.C.Y. & Cheng, D. Acyl-coenzyme A:cholesterol acyltransferase. Annu. Rev. Biochem. 66, 613–638 (1997). · DOI · Paper page
  3. Goodman, D.S. Cholesterol ester metabolism. Physiol. Rev. 45, 747–839 (1965). · DOI
  4. Chang, C.C.Y., Huh, H.Y., Cadigan, K.M. & Chang, T.Y. Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. 268, 20747–20755 (1993). · DOI
  5. Uelmen, P.J. et al. Tissue-specific expression and cholesterol regulation of acylcoenzyme A:cholesterol acyltransferase (ACAT) in mice. Molecular cloning of mouse ACAT cDNA, chromosomal localization, and regulation of ACAT in vivo and in vitro. J. Biol. Chem. 270, 26192–26201 (1995). · DOI
  6. Meiner, V. et al. Tissue expression studies of mouse acyl CoA:cholesterol acyltransferase gene (Acact): Findings supporting the existence of multiple cholesterol esterification enzymes in mice. J. Lipid Res. 38, 1928–1933 (1997). · DOI · Paper page
  7. Meiner, V.L. et al. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: Evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc. Natl. Acad. Sci. USA 93, 14041–14046 (1996). · DOI
  8. Anderson, R.A. et al. Identification of a form of Acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J. Biol. Chem. 273, 26747–26754 (1998). · DOI
  9. Cases, S. et al. ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization. J. Biol. Chem. 273, 26755–26764 (1998). · DOI · Paper page
  10. Oelkers, P., Behari, A., Cromley, D., Billheimer, J.T. & Sturley, S.L. Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes. J. Biol. Chem. 273, 26765–26771 (1998). · DOI
  11. Paigen, B., Morrow, A., Brandon, C., Mitchell, D. & Holmes, P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57, 65–73 (1985). · DOI
  12. Davis, R.A., McNeal, M.M. & Moses, R.L. Intrahepatic assembly of very low density lipoprotein. Competition by cholesterol esters for the hydrophobic core. J. Biol. Chem. 257, 2634–2640 (1982). · DOI
  13. Wang, D.Q.-H., Lammert, F., Cohen, D.E., Paigen, B. & Carey, M.C. Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis. Am. J. Physiol. 276, G751–G760 (1999). · DOI
  14. Sehayek, E. et al. Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. Proc. Natl. Acad. Sci. USA 95, 10194–10199 (1998). · DOI
  15. Wilson, M.D. & Rudel, L.L. Review of cholesterol absorption with emphasis on dietary and biliary cholesterol. J. Lipid Res. 35, 943–955 (1994). · DOI
  16. Young, S.G. et al. A genetic model for absent chylomicron formation: mice producing apolipoprotein B in the liver, but not in the intestine. J. Clin. Invest. 96, 2932–2946 (1995). · DOI
  17. Krause, B.R. & Bocan, T.M.A. ACAT inhibitors: physiologic mechanisms for hypolipidemic and anti-atherosclerotic activities in experimental animals. in Inflammation. Mediators and Pathways (eds. Ruffolo, R.R., Jr. & Hollinger, M.A.), 173–198 (CRC Press, Boca Raton,–Florida, 1995).
  18. Klein, R.L. & Rudel, L.L. Cholesterol absorption and transport in thoracic duct lymph lipoproteins of nonhuman primates. Effect of dietary cholesterol level. J. Lipid Res. 24, 343–356 (1983). · DOI
  19. Dixon, J.L. & Ginsberg, H.N. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J. Lipid Res. 34, 167–179 (1993). · DOI
  20. Purcell-Huynh, D.A. et al. Genetic factors in lipoprotein metabolism. Analysis of a genetic cross between inbred mouse strains NZB/BINJ and SM/J using a complete linkage map approach. J. Clin. Invest. 96, 1845–1858 (1995). · DOI
  21. Khanuja, B. et al. Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc. Natl. Acad. Sci. USA 92, 7729–7733 (1995). · DOI
  22. Machleder, D. et al. Complex genetic control of HDL levels in mice in response to an atherogenic diet. Coordinate regulation of HDL levels and bile acid metabolism. J. Clin. Invest. 99, 1406–1419 (1997). · DOI
  23. Lammert, F., Wang, D.Q.-H., Cohen, D.E., Paigen, B. & Carey, M.C. Functional and genetic studies of biliary cholesterol secretion in inbred mice: Evidence for a primary role of sister to P-glycoprotein, the canalicular bile salt export pump in cholesterol gallstone pathogenesis. in Bile Acids and Cholestasis (eds. Paumgartner, G., Stiehl, A., Gerok, W., Keppler, D. & Leuschner, U.), 224–228 (Kluwer Academic Publishers, Dordrecht, The–Netherlands, 1999).
  24. Smith, J.L., Hardie, I.R., Pillay, S.P. & de Jersey, J. Hepatic acyl-coenzyme A:cholesterol acyltransferase activity is decreased in patients with cholesterol gallstones. J. Lipid Res. 31, 1993–2000 (1990). · DOI
  25. Lee, O., Chang, C.C.Y., Lee, W. & Chang, T.-Y. Immunodepletion experiments suggest that acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT-1) protein plays a major catalytic role in adult human liver, adrenal gland, macrophages, and kidney, but not in intestines. J. Lipid Res. 39, 1722–1727 (1998). · DOI
  26. Chang, C.C.Y., Lee, O., Lin, S. & Chang, T.-Y. Quantitative analysis of human acyl-coenzyme A:cholesterol acyltransferase-1 and -2 (ACAT-1 and ACAT-2) in intestines, Caco-2 cells, HepG2 cells, adult and embryonic livers by using specific antibodies. Circulation 100, I–612 (1999).
  27. Chang, C.C.Y. et al. Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J. Biol. Chem. 275, 28083–28092 (2000). · DOI
  28. Accad, M. et al. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J. Clin. Invest. 105, 711–719 (2000). · DOI
  29. Mortensen, R. Production of a heterozygous mutant cell line by homologous recombination (single knockout). in Current Protocols in Molecular Biology Vol. 2 (eds. Ausubel, F.M. et al.), 9.16.1–9.16.11 (John Wiley & Sons, New–York, 1999).
  30. Farese, R.V.,Jr. et al. A novel function for apolipoprotein B: lipoprotein synthesis in the yolk sac is critical for maternal–fetal lipid transport in mice. J. Lipid Res. 37, 347–360 (1996). · DOI
  31. Smith, J.L., Lear, S.R. & Erickson, S.K. Developmental expression of elements of hepatic cholesterol metabolism in the rat. J. Lipid Res. 36, 641–652 (1995). · DOI
  32. Erickson, S.K., Shrewsbury, M.A., Brooks, C. & Meyer, D.J. Rat liver acyl-coenzyme A:cholesterol acyltransferase: its regulation in vivo and some of its properties in vitro. J. Lipid Res. 21, 930–941 (1980). · DOI
  33. Horie, Y., Fazio, S., Westerlund, J.R., Weisgraber, K.H. & Rall, S.C., Jr. The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia. J. Biol. Chem. 267, 1962–1968 (1992). · DOI · Paper page
  34. Schwarz, M., Russell, D.W., Dietschy, J.M. & Turley, S.D. Marked reduction in bile acid synthesis in cholesterol 7α-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia. J. Lipid Res. 39, 1833–1843 (1998). · DOI
  35. Jensen, D.R. et al. Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am. J. Physiol. 273, R683–R689 (1997).
  36. McCormick, S.P.A. et al. Transgenic mice that overexpress mouse apolipoprotein B. Evidence that the DNA sequences controlling intestinal expression of the apolipoprotein B gene are distant from the structural gene. J. Biol. Chem. 271, 11963–11970 (1996). · DOI
  37. Hamilton, R.L., Jr., Goerke, J., Guo, L.S.S., Williams, M.C. & Havel, R.J. Unilamellar liposomes made with the French pressure cell: A simple preparative and semiquantitative technique. J. Lipid Res. 21, 981–992 (1980). · DOI
  38. Turley, S.D., Daggy, B.P. & Dietschy, J.M. Psyllium augments the cholesterol-lowering action of cholestyramine in hamsters by enhancing sterol loss from the liver. Gastroenterology 107, 444–452 (1994). · DOI

Cited by

Sorted by citations

Metadata

Authors
Buhman, K. K., Accad, M., Novak, S., Choi, R. S., Wong, J. S., Hamilton, R. L., Turley, S., & Farese, R. V.
Venue
Nature Medicine
Published
2000-12
Volume
6
Issue
12
Pages
1341-1347
ISSN
  • 1078-8956
  • 1546-170X
Cited by
312
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review